Accounts Payable Analyst II

Pharmaceutical Product Development (PPD)

Shanghai, Shanghai, China

Work Schedule

Standard (Mon-Fri)

Environmental Conditions

Office

Job Description

How you will make an impact:

Seeking a Senior Accounts Payable to be focus in the Intercompany process and to ensure transactional excellence related to intercompany AR/AP.

They will partner with a broad number of external and internal business partners, such as Trade Partners, Procurement Team, Tax, Accounting, Compliance & Audit. The focus is on driving day to day Intercompany activities to achieve invoice booking efficiency, GIT, GRIR and input VAT goals.

What you will do:
  • Reporting and analytics on Intercompany related topics.
  • Arrange payment with schedule, provide payment details when required.
  • Collect invoices (Pre-call/prepare/send statements with current invoices), call on past due invoices, problem solve disputes with intercompany customer and CSR team.
  • Responsible for intercompany charge in/out.
  • Month-end intercompany AR reconciliation.
  • In charge of BS recon comments, BS reconciliation, check list and other related reports.
  • Work closely with FP&A, Tax to resolve charge out related.
  • Participate in trainings to engage non-finance teams in finance related compliance and processes.
  • Assist in establishing and maintaining appropriate internal controls to ensure 100% SOX compliance.
  • Participate in various finance projects and initiatives to drive improvements in execution.

How you will get here:

Education
  • Bachelor’s Degree

Experience
  • 4+ years of experience

Knowledge, Skills, Abilities
  • Ability to quickly learn organization specific computer applications, ability to learn accounting principles
  • Good spoken and written communication skills are required to collaborate with various partners
  • Proficient Excel skills and ERP experience (i.e. SAP, JDE)
  • High attention to detail and accuracy is a critical component of role

Travel Requirements
  • Less than 10%

Job posted: 2024-07-01

3
Subscribe